Benign prostatic hyperplasia

Affiliations

Editorial

J D McConnel. J Urol. 1995 Aug.

. 1995 Aug;154(2 Pt 1):402-3.

doi: 10.1097/00005392-199508000-00021.

¹ Division of Urology, University of Texas, Southwestern Medical Center, Dallas, Texas

No abstract available

Comment on

Prevalence of prostatism in Japanese men in a community-based study with comparison to a similar American study.
Tsukamoto T, Kumamoto Y, Masumori N, Miyake H, Rhodes T, Girman CJ, Guess HA, Jacobsen SJ, Lieber MM. Tsukamoto T, et al. J Urol. 1995 Aug;154(2 Pt 1):391-5. doi: 10.1097/00005392-199508000-00018. J Urol. 1995. PMID: 7541852
The correlation of multichannel urodynamic pressure-flow studies and American Urological Association symptom index in the evaluation of benign prostatic hyperplasia.
Ko DS, Fenster HN, Chambers K, Sullivan LD, Jens M, Goldenberg SL. Ko DS, et al. J Urol. 1995 Aug;154(2 Pt 1):396-8. doi: 10.1097/00005392-199508000-00019. J Urol. 1995. PMID: 7541853
Placebo controlled double-blind study to test the efficacy of the aromatase inhibitor atamestane in patients with benign prostatic hyperplasia not requiring operation. The Schering 90.062 Study Group.
Gingell JC, Knönagel H, Kurth KH, Tunn UW. Gingell JC, et al. J Urol. 1995 Aug;154(2 Pt 1):399-401. doi: 10.1097/00005392-199508000-00020. J Urol. 1995. PMID: 7541854 Clinical Trial.